Jai Mata Glass Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Jai Mata Glass Ltd is ₹ 2.84 as of 23 Oct 15:30 . The P/E Ratio of Jai Mata Glass Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Jai Mata Glass Ltd changed from ₹ 4.7 crore on March 2022 to ₹ 18 crore on March 2026 . This represents a CAGR of 30.81% over 5 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Jai Mata Glass Ltd for the Sep '26 is ₹ 0.09 crore as compare to the Jun '26 revenue of ₹ 0.04 crore. This represent the growth of 125% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Jai Mata Glass Ltd for the Sep '26 is ₹ -0.03 crore as compare to the Jun '26 ebitda of ₹ -0.06 crore. This represent the decline of -50% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Jai Mata Glass Ltd changed from ₹ 0.01 crore to ₹ -0.03 crore over 10 quarters. This represents a CAGR of NaN% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The Dividend Payout of Jai Mata Glass Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Jai Mata Glass Ltd

Jai Mata Glass Limited, formerly known Jai Mata Rolled Glass Limited was incorporated in February, 1981.
Initially, Company engaged in Glass business and is one of the leading name in designer glass. The company has an installed capacity to manufacture 5.2 mln SqM per annum of Rolled, Figured & Wired Glass.
The company has also facility to produce Lead Crystalware at Tipra, HP with an installed capacity of 1050 MTPA. The cost(Rs.11.6 Crore) for setting up of this lead Crystalware plant is part financed by an rights issue in Dec. '95. This 24% lead Crystalware unit has commenced commercial production in March '96.
The company's Unit II for manufacturing of rolled, figured and wired glass commenced commercial production on Feb 8, 2002. Company increased the annual installed capacity of rolled, figured & wired glass in May 2007, from 6.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Jai Mata Glass Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Jai Mata Glass Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Jai Mata Glass Ltd is 28 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Jai Mata Glass Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Jai Mata Glass Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jai Mata Glass Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Jai Mata Glass Ltd stock price is INR ₹2.84. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Jai Mata Glass Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Jai Mata Glass Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.